Factors Affecting the Quality of Life of Schizophrenia: Focused on Resilience

Jaeoh Jung; Eunsong Woo; Minsook Gim; Young-Min Choi

doi:10.4306/jknpa.2016.55.4.407

Journal List > J Korean Neuropsychiatr Assoc > v.55(4) > 1017823

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Jung, Woo, Gim, and Choi: Factors Affecting the Quality of Life of Schizophrenia: Focused on Resilience

Original Article

Journal of Korean Neuropsychiatric Association 2016; 55(4): 407-414.

Published online: 30 November 2016

DOI: https://doi.org/10.4306/jknpa.2016.55.4.407

Factors Affecting the Quality of Life of Schizophrenia: Focused on Resilience

Jaeoh Jung, MD¹, Eunsong Woo, MD¹, Minsook Gim, MD, PhD², Young-Min Choi, MD, PhD²

¹Department of Psychiatry, Seoul Metropolitan Eunpyeong Hospital, Seoul, Korea.

²Department of Psychiatry, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.

Address for correspondence: Eunsong Woo, MD. Department of Psychiatry, Seoul Metropolitan Eunpyeong Hospital, 90 Baengnyeonsan-ro, Eunpyeong-gu, Seoul 03476, Korea. Tel +82-2-300-8114, Fax +82-2-300-8255, stakato@seoul.go.kr

Received 2 September 2016 Revised 21 October 2016 Accepted 27 October 2016

Abstract

Objectives

The purpose of this study was to identify factors, including resilience, that influence the quality of life of schizophrenia patients.

Methods

Subjects included thirty-eight patients with schizophrenia. Each subject was administered questionnaires regarding their socio-demographic characteristics, resilience, quality of life, and social supports. Depressed mood severity and psychopathology of each patient were determined. The Korean version of the 4th revision of Schizophrenia Quality of Life assessment and the Korean modification of the Scale to Measure Subjective Well-being under Neuroleptic treatment were used to assess quality of life.

Results

Resilience, occupation, income, social supports, psychopathology, and depressed mood were correlated with quality of life. Multiple regression analysis results indicated that depressed mood and income have an effect on quality of life (R2=0.526, p=0.000). Moreover, resilience, social supports, and depressed mood also contributed to quality of life (R2=0.635, p=0.000).

Conclusion

The result of this study indicate that psychosocial factors including resilience should be considered when caring for schizophrenia patients.

Keywords: Schizophrenia, Resilience, Quality of life, Depression

Figures and Tables

Table 1

Comparison with resilience and quality of life by sociodemographic characteristics (n=38)

^* : p<0.05, ^† : p<0.01. CD-RISC : Conner-Davidson Resilience Scale, SQLS-R4K : Korean version of 4th revision of Schizophrenia Quality of Life, KmSWN : Korean modification of the Scale to measure Subjective Well-being under Neuroleptic treatment, SD : Standard deviation

Table 2

Correlations among SQLS-R4K, KmSWN, CD-RISC, FSSQ, PANSS, K-CDSS, and DDD

Pearson correlation analysis. ^* : p<0.05, ^† : p<0.01. SQLS-R4K : Korean version of 4th revision of Schizophrenia Quality of Life, KmSWN : Korean modification of the Scale to measure Subjective Well-being under Neuroleptic treatment, CD-RISC : Conner-Davidson Resilience Scale, FSSQ : The Duke-UNC Functional Social Support Questionnaire, PANSS : Positive and Negative Syndrome Scale, P : Positive scale, N : Negative scale, K-CDSS : Korean version of the Calgary Depression Scale for Schizophrenia, DDD : Defined Daily Dose

Table 3

Multiple regression analysis for scores of each QoL scale (n=38)

SQLS-R4K : Korean version of 4th revision of Schizophrenia Quality of Life, KmSWN : Korean modification of the Scale to measure Subjective Well-being under Neuroleptic treatment, K-CDSS : Korean version of the Calgary Depression Scale for Schizophrenia, CD-RISC : Conner-Davidson Resilience Scale, FSSQ : The Duke-UNC Functional Social Support Questionnaire, QoL : Quality of life

Notes

^{Conflicts of Interest} The authors have no financial conflicts of interest.

References

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association;2013. p. 102.

2. Carpenter WT Jr, Kirkpatrick B. The heterogeneity of the long-term course of schizophrenia. Schizophr Bull. 1988; 14:645–652.

3. Lambert M, Naber D. Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life. CNS Drugs. 2004; 18:Suppl 2. 5–17. discussion 41-43.

4. Awad AG, Voruganti LN, Heslegrave RJ. A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation. Qual Life Res. 1997; 6:21–26.

5. Awad AG, Voruganti LN. Intervention research in psychosis: issues related to the assessment of quality of life. Schizophr Bull. 2000; 26:557–564.

6. Margariti M, Ploumpidis D, Economou M, Christodoulou GN, Papadimitriou GN. Quality of life in schizophrenia spectrum disorders: associations with insight and psychopathology. Psychiatry Res. 2015; 225:695–701.

7. Eack SM, Newhill CE. Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophr Bull. 2007; 33:1225–1237.

8. Hamaideh S, Al-Magaireh D, Abu-Farsakh B, Al-Omari H. Quality of life, social support, and severity of psychiatric symptoms in Jordanian patients with schizophrenia. J Psychiatr Ment Health Nurs. 2014; 21:455–465.

9. Lee KU, Bahk WM. A new goal of treatment for schizophrenia: quality of life. Korean J Psychopharmacol. 2006; 17:13–23.

10. Rutter M. Implications of resilience concepts for scientific understanding. Ann N Y Acad Sci. 2006; 1094:1–12.

11. Luthar SS, Cicchetti D, Becker B. The construct of resilience: a critical evaluation and guidelines for future work. Child Dev. 2000; 71:543–562.

12. Masten AS. Resilience in children threatened by extreme adversity: frameworks for research, practice, and translational synergy. Dev Psychopathol. 2011; 23:493–506.

13. Fabrega H Jr. Psychiatric stigma in the classical and medieval period: a review of the literature. Compr Psychiatry. 1990; 31:289–306.

14. Avison WR, Speechley KN. The discharged psychiatric patient: a review of social, social-psychological, and psychiatric correlates of outcome. Am J Psychiatry. 1987; 144:10–18.

15. Jääskeläinen E, Juola P, Hirvonen N, McGrath JJ, Saha S, Isohanni M, et al. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2013; 39:1296–1306.

16. Cabanyes Truffino J. [Resilience: an approach to the concept]. Rev Psiquiatr Salud Ment. 2010; 3:145–151.

17. Kim KR, Song YY, Park JY, Lee EH, Lee M, Lee SY, et al. The relationship between psychosocial functioning and resilience and negative symptoms in individuals at ultra-high risk for psychosis. Aust N Z J Psychiatry. 2013; 47:762–771.

18. Tait L, Birchwood M, Trower P. Adapting to the challenge of psychosis: personal resilience and the use of sealing-over (avoidant) coping strategies. Br J Psychiatry. 2004; 185:410–415.

19. Wartelsteiner F, Mizuno Y, Frajo-Apor B, Kemmler G, Pardeller S, Sondermann C, et al. Quality of life in stabilized patients with schizophrenia is mainly associated with resilience and self-esteem. Acta Psychiatr Scand. 2016; 134:360–367.

20. Palmer BW, Martin AS, Depp CA, Glorioso DK, Jeste DV. Wellness within illness: happiness in schizophrenia. Schizophr Res. 2014; 159:151–156.

21. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995; 41:1403–1409.

22. Bozikas V, Parlapani E. Resilience in patients with psychotic disorder. Psychiatriki. 2016; 27:13–16.

23. Kim JH, Yim SJ, Min SK, Kim SE, Son SJ, Wild DJ, et al. The Korean version of 4th Revision of Schizophrenia Quality of Life Scale: validation study and relationship with PANSS. J Korean Neuropsychiatr Assoc. 2006; 45:401–410.

24. Yoon JS, Kook SH, Lee HY, Lee C, Paik IH. The development of a Korean modification of the Scale to Measure Subjective Well-being under Neuroleptic treatment (KmSWN). J Korean Neuropsychiatr Assoc. 2000; 39:987–998.

25. Wilkinson G, Hesdon B, Wild D, Cookson R, Farina C, Sharma V, et al. Self-report quality of life measure for people with schizophrenia: the SQLS. Br J Psychiatry. 2000; 177:42–46.

26. Naber D. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol. 1995; 10:Suppl 3. 133–138.

27. Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003; 18:76–82.

28. Baek HS, Lee KU, Joo EJ, Lee MY, Choi KS. Reliability and validity of the Korean version of the connor-davidson resilience scale. Psychiatry Investig. 2010; 7:109–115.

29. Broadhead WE, Gehlbach SH, de Gruy FV, Kaplan BH. The Duke-UNC Functional Social Support Questionnaire. Measurement of social support in family medicine patients. Med Care. 1988; 26:709–723.

30. Suh SY, Im YS, Lee SH, Park MS, Yoo T. A study for the development of Korean version of the Duke-UNC functional social support questionnaire. J Korean Acad Fam Med. 1997; 18:250–260.

31. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987; 13:261–276.

32. Yi JS, Ahn YM, Shin HK, An SK, Joo YH, Kim SH, et al. Reliability and validity of the Korean version of the positive and negative syndrome scale. J Korean Neuropsychiatr Assoc. 2001; 40:1090–1105.

33. WHO Collaborating Centre for Drug Statistics Methodology. cited 2016 Aug 30. Available from: http://www.whocc.no/atc_ddd_index/.

34. Addington D, Addington J, Maticka-Tyndale E, Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophr Res. 1992; 6:201–208.

35. Kim YK, Won SD, Lee KM, Choi HS, Jang HS, Lee BH, et al. A study on the reliability and validity of the Korean version of the Calgary Depression Scale for Schizophrenia (K-CDSS). J Korean Neuropsychiatr Assoc. 2005; 44:446–455.

36. Alessandrini M, Lançon C, Fond G, Faget-Agius C, Richieri R, Faugere M, et al. A structural equation modelling approach to explore the determinants of quality of life in schizophrenia. Schizophr Res. 2016; 171:27–34.

37. Jang CH, Ahn DH, Lee JI. The quality of life and related psychosocial factors of schizophrenia patients registered in community mental health center. Korean J Biol Psychiatry. 2014; 21:28–35.

38. Tomotake M. Quality of life and its predictors in people with schizophrenia. J Med Invest. 2011; 58:167–174.

39. Mauriño J, Sanjúan J, Haro JM, Díez T, Ballesteros J. Impact of depressive symptoms on subjective well-being: the importance of patient-reported outcomes in schizophrenia. Patient Prefer Adherence. 2011; 5:471–474.

40. Suttajit S, Pilakanta S. Predictors of quality of life among individuals with schizophrenia. Neuropsychiatr Dis Treat. 2015; 11:1371–1379.

41. Siris SG. Depression in schizophrenia: perspective in the era of “Atypical” antipsychotic agents. Am J Psychiatry. 2000; 157:1379–1389.

42. Yoo SY. Developing a prediction model for quality of life in patients with schizophrenia. J Korean Acad Psychiatr Ment Health Nurs. 2014; 23:144–155.

43. Seo DD, Choi KS, Park WR, Lee MR, Kim DY, Yu JC. The effects of mental fitness, social support and psychological distress on suicidal idea of people with schizophrenia using community mental health services. J Korean Neuropsychiatr Assoc. 2014; 53:364–369.

44. Kim KJ, Seol JH, Paik YS, Kim JH. The relationship between quality of life and psychosocial characteristics in patients with schizophrenia. J Korean Neuropsychiatr Assoc. 2004; 43:603–610.

45. Suh HS, Kim CH, Lee HS, Jung YC, Choi YH, Huh SY, et al. Quality of life and psychopathology in patients with schizophrenia: subjective and objective assessment. J Korean Neuropsychiatr Assoc. 2001; 40:1122–1131.

46. Lim M, Sim M, Chae S, Lee WH, Na J, Kim D. Stress coping strategies and quality of life in patients with schizophrenia. J Korean Neuropsychiatr Assoc. 2015; 54:181–187.

47. Shah R, Kulhara P, Grover S, Kumar S, Malhotra R, Tyagi S. Contribution of spirituality to quality of life in patients with residual schizophrenia. Psychiatry Res. 2011; 190:200–205.

48. Mizuno Y, Hofer A, Suzuki T, Frajo-Apor B, Wartelsteiner F, Kemmler G, et al. Clinical and biological correlates of resilience in patients with schizophrenia and bipolar disorder: a cross-sectional study. Schizophr Res. 2016; 175:148–153.

49. Bozikas VP, Parlapani E, Holeva V, Skemperi E, Bargiota SI, Kirla D, et al. Resilience in patients with recent diagnosis of a schizophrenia spectrum disorder. J Nerv Ment Dis. 2016; 204:578–584.

50. Yoshida K, Suzuki T, Imasaka Y, Kubo K, Mizuno Y, Saruta J, et al. Resilience in schizophrenia: a comparative study between a remote island and an urban area in Japan. Schizophr Res. 2016; 171:92–96.

51. Torgalsbøen AK. Sustaining full recovery in schizophrenia after 15 years: does resilience matter? Clin Schizophr Relat Psychoses. 2012; 5:193–200.

52. Galderisi S, Rossi A, Rocca P, Bertolino A, Mucci A, Bucci P, et al. The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia. World Psychiatry. 2014; 13:275–287.

53. Kane JM, Robinson DG, Schooler NR, Mueser KT, Penn DL, Rosenheck RA, et al. Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program. Am J Psychiatry. 2016; 173:362–372.

54. Mueser KT, Penn DL, Addington J, Brunette MF, Gingerich S, Glynn SM, et al. The NAVIGATE program for first-episode psychosis: rationale, overview, and description of psychosocial components. Psychiatr Serv. 2015; 66:680–690.

TOOLS

Similar articles